Actively Recruiting
MELIORA Data Collection Campaigns
Led by Harokopio University · Updated on 2025-09-30
300
Participants Needed
7
Research Sites
23 weeks
Total Duration
On this page
Sponsors
H
Harokopio University
Lead Sponsor
B
BROSTCANCERFORENINGEN AMAZONA I STOCKHOLMS LAN
Collaborating Sponsor
AI-Summary
What this Trial Is About
To support the development of the MELIORA digital app for the MELIORA main intervention, an initial pilot study (Data Collection Campaign, DCC) is being conducted with the three target participant groups: healthy women at increased risk of developing breast cancer (BC), BC patients, and BC survivors across the four intervention countries (Spain, Greece, Lithuania, Sweden). The planned sample size for each group is 156 healthy women at risk (defined as not meeting recommendations for a healthy lifestyle), 58 BC patients, and 86 BC survivors. Each participant is asked to test and evaluate a preliminary version of the MELIORA app over a 14-day period. The DCC takes place in the early stages of the project, as part of the intervention development phase, to inform the technical refinement and preliminary evaluation of the MELIORA digital app.
CONDITIONS
Official Title
MELIORA Data Collection Campaigns
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals residing in Greece, Lithuania, Spain or Sweden
- Female adults aged 18 years or older
- Ability to understand and complete outcome measures in a local language of the participating countries
- Ability to provide fully informed consent
- Access to and ability to use a smartphone that supports the MELIORA app (iOS or Android)
- Healthy women with BMI ≥ 25 or not meeting WHO recommendations of ≥150 minutes of moderate-to-vigorous physical activity per week
- Women currently undergoing active breast cancer treatment or awaiting active treatment
- Breast cancer survivors who completed active treatment at least six months prior to enrollment
You will not qualify if you...
- Inability to provide fully informed consent
- Inability to understand or communicate in one of the recruitment countries' local languages
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Harokopio University
Athens, Greece
Actively Recruiting
2
Lietuvos Sveikatos Mokslų Universitetas (Lsmu)
Kaunas, Lithuania
Actively Recruiting
3
Pagalbos Onkologiniams Ligoniams Asociacija (Pola L T)
Kaunas, Lithuania
Actively Recruiting
4
Fundación Para El Fomento de La Investigación Sanitaria Y Biomédica de La Comunitat Valenciana (Fisabio)
Valencia, Spain
Actively Recruiting
5
INCLIVA - Instituto de Investigación Sanitaria
Valencia, Spain
Actively Recruiting
6
Bröstcancerföreningen Amazona I Stockholms Län (Amazona)
Stockholm, Sweden
Actively Recruiting
7
Karolinska Institutet
Stockholm, Sweden
Actively Recruiting
Research Team
Y
Yannis Manios, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here